MPI STANNOUS DIPHOSPHONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mpi Stannous Diphosphonate, and when can generic versions of Mpi Stannous Diphosphonate launch?
Mpi Stannous Diphosphonate is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in MPI STANNOUS DIPHOSPHONATE is technetium tc-99m etidronate kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m etidronate kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MPI STANNOUS DIPHOSPHONATE?
- What are the global sales for MPI STANNOUS DIPHOSPHONATE?
- What is Average Wholesale Price for MPI STANNOUS DIPHOSPHONATE?
Summary for MPI STANNOUS DIPHOSPHONATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| DailyMed Link: | MPI STANNOUS DIPHOSPHONATE at DailyMed |
US Patents and Regulatory Information for MPI STANNOUS DIPHOSPHONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | MPI STANNOUS DIPHOSPHONATE | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017667-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
